Page last updated: 2024-08-26

zofenopril and Arteriosclerosis

zofenopril has been researched along with Arteriosclerosis in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ambrosioni, E; Bacchelli, S; Borghi, C	1
Aleotti, L; Bucci, M; Casini, A; Cicala, C; Cirino, G; D'Armiento, FP; de Nigris, F; Franconi, F; Napoli, C; Roviezzo, F; Somma, P; Zuliani, P	1
Andreini, I; Bonaduce, D; Casini, A; Condorelli, M; D'Armiento, FP; de Nigris, F; De Rosa, G; Mansueto, G; Napoli, C; Sarlo, F; Somma, P	1

Reviews

1 review(s) available for zofenopril and Arteriosclerosis

Article	Year
The use of zofenopril and fosinopril in acute myocardial infarction and carotid artery disease. American journal of hypertension, 1994, Volume: 7, Issue:9 Pt 2 Topics: Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Captopril; Carotid Artery Diseases; Clinical Trials as Topic; Fosinopril; Humans; Myocardial Infarction	1994

Other Studies

2 other study(ies) available for zofenopril and Arteriosclerosis

Article	Year
Beneficial effects of ACE-inhibition with zofenopril on plaque formation and low-density lipoprotein oxidation in watanabe heritable hyperlipidemic rabbits. General pharmacology, 1999, Volume: 33, Issue:6 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Blood Platelets; Captopril; Female; Hyperlipoproteinemia Type II; Immunohistochemistry; Lipoproteins, LDL; Male; Rabbits	1999
Chronic treatment with sulfhydryl angiotensin-converting enzyme inhibitors reduce susceptibility of plasma LDL to in vitro oxidation, formation of oxidation-specific epitopes in the arterial wall, and atherogenesis in apolipoprotein E knockout mice. International journal of cardiology, 2001, Volume: 81, Issue:2-3 Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Valve Stenosis; Apolipoproteins E; Arteries; Arteriosclerosis; Blood Pressure; Captopril; Cholesterol; Disease Models, Animal; Dose-Response Relationship, Drug; Enalapril; Epitopes; Immunohistochemistry; Lipid Peroxidation; Lipoproteins, LDL; Male; Mice; Mice, Knockout; Oxidation-Reduction; Oxidative Stress; Peptidyl-Dipeptidase A; Random Allocation; Sulfhydryl Reagents; Time Factors; Treatment Outcome	2001

Article

Year

Beneficial effects of ACE-inhibition with zofenopril on plaque formation and low-density lipoprotein oxidation in watanabe heritable hyperlipidemic rabbits.

General pharmacology, 1999, Volume: 33, Issue:6

Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arteriosclerosis; Blood Platelets; Captopril; Female; Hyperlipoproteinemia Type II; Immunohistochemistry; Lipoproteins, LDL; Male; Rabbits

1999

Chronic treatment with sulfhydryl angiotensin-converting enzyme inhibitors reduce susceptibility of plasma LDL to in vitro oxidation, formation of oxidation-specific epitopes in the arterial wall, and atherogenesis in apolipoprotein E knockout mice.

International journal of cardiology, 2001, Volume: 81, Issue:2-3

Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Valve Stenosis; Apolipoproteins E; Arteries; Arteriosclerosis; Blood Pressure; Captopril; Cholesterol; Disease Models, Animal; Dose-Response Relationship, Drug; Enalapril; Epitopes; Immunohistochemistry; Lipid Peroxidation; Lipoproteins, LDL; Male; Mice; Mice, Knockout; Oxidation-Reduction; Oxidative Stress; Peptidyl-Dipeptidase A; Random Allocation; Sulfhydryl Reagents; Time Factors; Treatment Outcome

2001